ACM
ABBV icon

Adalta Capital Management’s AbbVie ABBV Stock Holding History

Adalta Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Hold
897
– – 0.09% 87
2025
Q4 		$205K Sell
897
-19
-2% -$4.33K 0.09% 83
2025
Q3 		$212K Hold
916
– – 0.1% 78
2025
Q2 		$170K Hold
916
– – 0.09% 77
2025
Q1 		$192K Buy
+916
New +$178K 0.1% 72

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adalta Capital Management's ABBV Position: Q1 2026 in Review

Adalta Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 897 shares worth $195K. The position accounts for 0.09% of the portfolio, ranked #87.

Adalta Capital Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $212K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Adalta Capital Management held 897 shares of AbbVie worth $195K as of Q1 2026.
  • Adalta Capital Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.09% of Adalta Capital Management's portfolio in Q1 2026, its #87 holding.
  • Adalta Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Adalta Capital Management's AbbVie position peaked at $212K in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Adalta Capital Management's 13F filing for Q1 2026, filed 18 May 2026.